U., P., K., T., P., D., S., S., & N., C. (2017). Cost-effectiveness of insulin detemir versus insulin glargine for Thai type 2 diabetes from a payer’s perspective.

U., Permsuwan, Thavorn K., Dilokthornsakul P., Saokaew S., و Chaiyakunapruk N. Cost-effectiveness of Insulin Detemir Versus Insulin Glargine for Thai Type 2 Diabetes From a Payer’s Perspective. 2017.

U., Permsuwan, et al. Cost-effectiveness of Insulin Detemir Versus Insulin Glargine for Thai Type 2 Diabetes From a Payer’s Perspective. 2017.